<html><body><div style="width:400px;"><div class="tracker" data-tracker-id="twitter_1543257966823997440"><blockquote class="twitter-tweet"><p lang="en" dir="ltr">On their own, DBS/LITT, etc are interesting but probably slowish growth each year. <br>DBS: 10-15%<br>LITT: 15%<br>ok, but not eye-popping.<br><br>CLPT as a platform w/MRI + operating room uses, drug delivery + &quot;CRO-like&quot; services w/each area driving adoption for other uses = very interesting</p>&mdash; Guillermo (@NeuroStockDoc) <a href="https://twitter.com/NeuroStockDoc/status/1543257966823997440?ref_src=twsrc%5Etfw">July 2, 2022</a></blockquote>

</div></div></body><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></html>